Skip to main content

Research Repository

Advanced Search

In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer.

Hoskins, Clare; Ouaissi, Mehdi; Lima, Sofia Costa; Cheng, Woei Ping; Loureirio, In�s; Mas, Eric; Lombardo, Dominique; Cordeiro-da-Silva, Anabela; Ouaissi, Ali; Kong Thoo Lin, Paul

Authors

Clare Hoskins

Mehdi Ouaissi

Sofia Costa Lima

Woei Ping Cheng

In�s Loureirio

Eric Mas

Dominique Lombardo

Anabela Cordeiro-da-Silva

Ali Ouaissi



Abstract

Purpose: To evaluate the in vitro and in vivo pancreatic anticancer activity of a nano-sized formulation based on novel polyallylamine grafted with 5% mole cholesteryl pendant groups (CH5-PAA). Methods: Insoluble novel anticancer drug, Bisnaphthalimidopropyldiaaminooctane (BNIPDaoct), was loaded into CH5-PAA polymeric self-assemblies by probe sonication. Hydrodynamic diameters and polydispersity index measurements were determined by photon correlation spectroscopy. The in vitro cytotoxicity evaluation of the formulation was carried out by the sulforhodamine B dye assay with human pancreatic adenocarcinoma BxPC-3 cells, while for the in vivo study, Xenograff mice were used. In vitro apoptotic cell death from the drug formulation was confirmed by flow cytometric analysis. Results: The aqueous polymer-drug formulation had a mean hydrodynamic size of 183 nm. The drug aqueous solubility was increased from negligible concentration to 0.3 mg mL−1. CH5-PAA polymer alone did not exhibit cytotoxicity, but the new polymer-drug formulation showed potent in vitro and in vivo anticancer activity. The mode of cell death in the in vitro study was confirmed to be apoptotic. The in vivo results revealed that the CH5-PAA alone did not have any anti-proliferative effect, but the CH5-PAA-drug formulation exhibited similar tumour reduction efficacy as the commercial drug, gemcitabine. Conclusions: The proposed formulation shows potential as pancreatic cancer therapeutics.

Citation

HOSKINS, C., OUAISSI, M., LIMA, S.C., CHENG, W.P., LOUREIRIO, I., MAS, E., LOMBARDO, D., CORDEIRO-DA-SILVA, A., OUAISSI, A. and KONG THOO LIN, P. 2010. In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer. Pharmaceutical research [online], 27(12), pages 2694-2703. Available from: https://doi.org/10.1007/s11095-010-0268-6

Journal Article Type Article
Acceptance Date Aug 30, 2010
Online Publication Date Sep 25, 2010
Publication Date Dec 31, 2010
Deposit Date Aug 23, 2022
Publicly Available Date Sep 12, 2022
Journal Pharmaceutical Research
Print ISSN 0724-8741
Electronic ISSN 1573-904X
Publisher American Association of Pharmaceutical Scientists
Peer Reviewed Peer Reviewed
Volume 27
Issue 12
Pages 2694-2703
DOI https://doi.org/10.1007/s11095-010-0268-6
Keywords Amphiphilic polyallylamine; Apoptosis; Bisnaphthalimidopropyl-diaminooctane; BxPC-3 cells; Nanoparticles; Pancreatic cancer; Self-assembling polymers
Public URL https://rgu-repository.worktribe.com/output/865522

Files

HOSKINS 2010 In vitro and in vivo anticancer (AAM) (725 Kb)
PDF

Copyright Statement
This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use [https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms], but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s11095-010-0268-6







You might also like



Downloadable Citations